English | 繁體

Search in the results

UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Clinical Benefit of First-Line Programmed Death-1 Antibody Plus Chemotherapy in Low Programmed Cell Death Ligand 1-Expressing Esophageal Squamous Cell Carcinoma: A Post Hoc Analysis of JUPITER-06 and Meta-Analysis Journal article
Wu, Hao Xiang, Pan, Yi Qian, He, Ye, Wang, Zi Xian, Guan, Wen Long, Chen, Yan Xing, Yao, Yi Chen, Shao, Ning Yi, Xu, Rui Hua, Wang, Feng. Clinical Benefit of First-Line Programmed Death-1 Antibody Plus Chemotherapy in Low Programmed Cell Death Ligand 1-Expressing Esophageal Squamous Cell Carcinoma: A Post Hoc Analysis of JUPITER-06 and Meta-Analysis[J]. Journal of Clinical Oncology, 2023, 41(9), 1735-1746.
Authors:  Wu, Hao Xiang;  Pan, Yi Qian;  He, Ye;  Wang, Zi Xian;  Guan, Wen Long; et al.
Favorite | TC[WOS]:30 TC[Scopus]:32  IF:42.1/37.4 | Submit date：2023/04/03
Pembrolizumab  Placebo  Camrelizumab  Nivolumab  Survival  Efficacy  Therapy  Safety  Chemo  
Fluorescence intensity and lifetime imaging of lipofuscin-like autofluorescence for label-free predicting clinical drug response in cancer Journal article
Yan, Yinghan, Xing, Fuqiang, Cao, Jiayue, Hu, Yiling, Li, Ling, Cao, Zhengyin, Jia, Hao, Miao, Kai, Shao, Fangyuan, Deng, Chu-Xia, Luo, Kathy Qian, Lee, Leo Tsz on, Liu, Tzu-Ming. Fluorescence intensity and lifetime imaging of lipofuscin-like autofluorescence for label-free predicting clinical drug response in cancer[J]. Redox Biology, 2023, 59(102578), 1-12.
Authors:  Yan, Yinghan;  Xing, Fuqiang;  Cao, Jiayue;  Hu, Yiling;  Li, Ling; et al.
Adobe PDF | Favorite | TC[WOS]:7 TC[Scopus]:10  IF:10.7/11.7 | Submit date：2022/12/27
Apoptosis  Autofluorescence  Label-free  Lipofuscin  Necrosis  
Stable and Efficient Blue-Emitting CsPbBr3 Nanoplatelets with Potassium Bromide Surface Passivation Journal article
Hao Lin, Qi Wei, Kar Wei Ng, Jia-Yi Dong, Jie-Lei Li, Wei-Wei Liu, Shan-Shan Yan, Shi Chen, Gui-Chuan Xing, Xiao-Sheng Tang, Zi-Kang Tang, Shuang-Peng Wang. Stable and Efficient Blue-Emitting CsPbBr3 Nanoplatelets with Potassium Bromide Surface Passivation[J]. Small, 2021, 17(43), 2101359.
Authors:  Hao Lin;  Qi Wei;  Kar Wei Ng;  Jia-Yi Dong;  Jie-Lei Li; et al.
Favorite | TC[WOS]:48 TC[Scopus]:53  IF:13.0/13.5 | Submit date：2021/09/10
AZ32 Reverses ABCG2-Mediated Multidrug Resistance in Colorectal Cancer Journal article
Liu, Kun, Li, Yan Chi, Chen, Yu, Shi, Xiao Bao, Xing, Zi Hao, He, Zheng Jie, Wang, Sheng Te, Liu, Wei Jing, Zhang, Peng Wei, Yu, Ze Zhong, Mo, Xue Mei, Chen, Mei Wan, Chen, Zhe Sheng, Shi, Zhi. AZ32 Reverses ABCG2-Mediated Multidrug Resistance in Colorectal Cancer[J]. Frontiers in Oncology, 2021, 11, 680663.
Authors:  Liu, Kun;  Li, Yan Chi;  Chen, Yu;  Shi, Xiao Bao;  Xing, Zi Hao; et al.
Favorite | TC[WOS]:8 TC[Scopus]:7  IF:3.5/4.0 | Submit date：2021/12/07
Abcg2  Az32  Colorectal Cancer  Crispr  Multidrug Resistance  
Elevated GTP Cyclohydrolase i Pathway in Endothelial Progenitor Cells of Overweight Premenopausal Women Journal article
Wu,Shaohong, He,Hao, Liu,Ge Xiu, Li,Xiao Peng, Yao,Shun, Su,Huan Xing, Li,Xiang, Ren,Zi, Zeng,Haitao, Liao,Jinli. Elevated GTP Cyclohydrolase i Pathway in Endothelial Progenitor Cells of Overweight Premenopausal Women[J]. Cardiology Research and Practice, 2020, 2020, 5914916.
Authors:  Wu,Shaohong;  He,Hao;  Liu,Ge Xiu;  Li,Xiao Peng;  Yao,Shun; et al.
Favorite | TC[WOS]:2 TC[Scopus]:3  IF:1.8/1.9 | Submit date：2021/03/01